Newsfeeds - Spark Newswire

1 minute read

Events
News

Graphite Bio Announces Participation In Upcoming Jefferies Gene Therapy/Editing Summit

October 21, 8:04 AM

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, announced today that members of the

GRPH

2 minute read

3 Stocks Insiders Are Buying

By Lisa Levin

October 18, 4:37 AM

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

CGTX

2 minute read

FDA
News

Graphite Bio Presents Preclinical Data Supporting GPH101 In Sickle Cell Disease At 49th Annual Sickle Cell Disease Association Of America National Convention

By Benzinga Newsdesk

October 12, 1:02 PM

GRPH

8 minute read

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

By Shanthi Rexaline

October 8, 7:31 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

ABIO

7 minute read

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

By Shanthi Rexaline

October 7, 8:23 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)

ADVM

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

October 6, 7:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

1 minute read

Events
News

Graphite Bio To Present At Sickle Cell Disease Association Of America National Oct. 12 at 1 p.m. EDT

By Benzinga Newsdesk

October 5, 8:21 AM

GRPH

4 minute read

The Daily Biotech Pulse: Restricted Authorization For Pfizer’s COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data

By Shanthi Rexaline

September 23, 7:56 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22)

ABCL

6 minute read

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

By Shanthi Rexaline

August 20, 7:45 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

ABVC

1 minute read

Graphite Bio Q2 EPS $(3.45) Down From $(0.56) YoY

By Benzinga Newsdesk

August 12, 4:52 PM

Graphite Bio (NASDAQ:GRPH) reported quarterly losses of $(3.45) per share. This is a 516.07 percent decrease over losses of $(0.56) per share from the same period last year.

GRPH